Dr Christopher Lowry
Christopher A. Lowry, Ph.D. is an Associate Professor in the Department of Integrative Physiology at the University of Colorado Boulder, with a secondary appointment in the Department of Physical Medicine and Rehabilitation (PM&R), University of Colorado Anschutz Medical Campus, School of Medicine, a member of the Centers for Neuroscience at CU-Boulder and the University of Colorado Anschutz Medical Campus, a Principal Investigator in the Department of Veterans Affairs Eastern Colorado Health Care System, VA Rocky Mountain Mental Illness Research, Education, & Clinical Center (MIRECC), Denver Veterans Affairs Medical Center (VAMC), and director of the Behavioral Neuroendocrinology Laboratory at CU-Boulder.
Dr Lowry was recently awarded a Young Investigator award from the Brain & Behaviour Research Foundation, a National Science Foundation CAREER award, and the Donald F. Klein Early Career Investigator Award from the Anxiety Disorders Association of America. He is a member of The American Gut Consortium, working to characterize the human gut microbiome based on data from a sample of >5000 individuals in The American Gut Project. He is also Co-Founder and Co-Director, with Dr. Lisa Brenner, of the Military and Veteran Microbiome Consortium for Research and Education (MVM-CoRE).
Dr Lowry’s research program focuses on understanding 1) stress-related physiology and behaviour with an emphasis on the role of serotonin, a chemical signaling molecule in the body and the brain, and 2) neural mechanisms underlying anxiety and affective disorders, and development of novel strategies for both the prevention and treatment of these disorders and their medical comorbidity, such as allergy, asthma, and inflammatory bowel disease. He has published ~115 peer-reviewed articles and is currently an editorial board member for Stress: The International Journal on the Biology of Stress. The Office of Naval Research, National Institutes of Health, Department of Veterans Affairs Office of Research and Development (VA-ORD), Colorado Clinical & Translational Sciences Institute (CCTSI) Center for Neuroscience, the Colorado Department of Public Health and Environment (CDPHE), and the Alfred P. Sloan Foundation currently fund his research. He joined Immodulon's Scientific Advisory Board in March 2016.